Results 101 to 110 of about 3,260 (145)

Three generations, one target: BTK inhibitors in lymphoma. [PDF]

Blood Adv
Schmitt A, Hailfinger S.
europepmc   +1 more source

Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells. [PDF]

Blood Adv
Pizzarella D, Kofides A, Hatcher JM, Liu X, Guijosa A, Tsakmaklis N, Peachey AL, Wang J, Guerrera ML, Patterson CJ, Hunter ZR, Sun H, Sarosiek SR, Castillo JJ, Buhrlage SJ, Dhe-Paganon S, Branagan AR, Treon SP, Liu S.   +18 more
europepmc   +1 more source

Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study. [PDF]

Br J Haematol
Zelmat Y, Ysebaert L, Gautier P, Sommet A, Lafaurie M, Despas F.   +5 more
europepmc   +1 more source

Case Report: Frontline CD19 CAR-T-cell therapy combined with targeted regimens induces durable complete remission in newly diagnosed secondary CNS lymphoma: a report of two cases. [PDF]

Front Oncol
Pan Q, Zhao R, Yang J, Guo H, Gao F, Liu X, Zhang Q, Jiao X, Zhou K.   +8 more
europepmc   +1 more source

Zanubrutinib potentiates polatuzumab vedotin efficacy in DLBCL with concurrent CD79b upregulation. [PDF]

Ann Hematol
Zhou X, Li J, Zhao Z, Liu J, Zhang J, Zhou W, Gui A, Yan Y, Zhu S, Liu W, Zuo J, Zhang Q, Yang L.   +12 more
europepmc   +1 more source

Durability Benchmarking of Contemporary Second-Line and Later Therapies for Relapsed or Refractory Follicular Lymphoma Using Reconstructed Individual Patient Data From Published Kaplan-Meier Curves. [PDF]

Cureus
Burke OJ, Peruzzo N, Tul Ain Khan N, Kancharla P.   +3 more
europepmc   +1 more source

Case Report: Discordant diffuse large B-cell lymphoma and splenic peripheral T-cell lymphoma revealed by persistent splenomegaly and cytopenia. [PDF]

Front Oncol
Ruan Z, Fan G, Xu L.
europepmc   +1 more source

Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma. [PDF]

Blood Adv
Song Z, Cheng Y, Yang H, Zhang L, Zou L, Guo Y, Cao J, Huang H, Wang Z, Huang S, Fang Y, Lyu J, Zhang Y, Liu Y, Zhou K, Zhang H.   +15 more
europepmc   +1 more source

Continuous or fixed-duration BTK inhibitor treatment for WM. [PDF]

Blood Adv
Yi S, Qiu L.
europepmc   +1 more source

Recurrence of B-cell Lymphoma Manifesting as Progressive Peripheral and Cranial Nerve Neuropathies: A Case Report. [PDF]

Cureus
Schofield S, Sehmbi G, Tun S, Buccoliero R.   +3 more
europepmc   +1 more source